Streptokinase biosimilar (Shantha Biotechnics)

链激酶生物类似药 (Shantha Biotechnics)

Report date: 2022/02/18 16:22:14

Base Information

Drug NameStreptokinase biosimilar (Shantha Biotechnics)

Drug Alias Name链激酶生物仿制药 (Shantha Biotechnics)Shankinase

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionPlasminogen stimulants

TargetsPlasminogen

Therapy Area/IndicationsMyocardial Infarction

Global Approved IndicationsMyocardial Infarction

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2004/01/01

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesShantha Biotechnics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShantha Biotechnics Ltd

Inactive CompaniesN/A

Active IndicationsMyocardial Infarction

Inactive IndicationsN/A

Other Information

ATC CodeB01AD01